Kiadis secures EUR15M debt financing

Hematological company Kiadis Pharma N.V. (Euronext:KDS) drew down €10 million ($11.7 million) on Aug. 17 in the first tranche of a €15 million ($17.6 million) debt financing from Kreos Capital. The s...